Article Details

PROTACs oncology market to reach $3.7 bn by 2030 despite regulatory challenges: GlobalData

Retrieved on: 2024-06-04 14:32:39

Tags for this article:

Click the tags to see associated articles and topics

PROTACs oncology market to reach $3.7 bn by 2030 despite regulatory challenges: GlobalData. View article details on hiswai:

Excerpt

GlobalData's analyst consensus forecasts reveal that PROTACs will enjoy lucrative sales, especially Arvinas/Pfizer ... Pfizer's Ibrance (palbociclib) in ...

Article found on: health.economictimes.indiatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up